These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7864945)

  • 1. Modified test for activated protein C resistance.
    Jorquera JI; Montoro JM; Fernández MA; Aznar JA; Aznar J
    Lancet; 1994 Oct; 344(8930):1162-3. PubMed ID: 7864945
    [No Abstract]   [Full Text] [Related]  

  • 2. A more discriminating test for APC resistance and a possible screening test to include protein C and protein S.
    Denson KW; Haddon ME; Reed SV; Davidson S; Littlewood TJ
    Thromb Res; 1996 Jan; 81(1):151-6. PubMed ID: 8747530
    [No Abstract]   [Full Text] [Related]  

  • 3. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract.
    Martorell JR; Muñoz-Castillo A; Gil JL
    Thromb Haemost; 1995 Aug; 74(2):796-7. PubMed ID: 8585026
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma.
    Strobl FJ; Hoffman S; Huber S; Williams EC; Voelkerding KV
    Arch Pathol Lab Med; 1998 May; 122(5):430-3. PubMed ID: 9593344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the functional assay for activated protein C resistance and factor V Leiden in the neonate.
    Sifontes MT; Nuss R; Hunger SP; Jacobson LJ; Waters J; Manco-Johnson MJ
    Pediatr Res; 1997 Dec; 42(6):776-8. PubMed ID: 9396556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. The APC Resistance Study Group.
    Rosén S; Johansson K; Lindberg K; Dahlbäck B
    Thromb Haemost; 1994 Aug; 72(2):255-60. PubMed ID: 7831662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance and inherited thrombosis.
    Rodgers GM
    Am J Clin Pathol; 1995 Mar; 103(3):261-2. PubMed ID: 7872247
    [No Abstract]   [Full Text] [Related]  

  • 9. High sensitivity and specificity of a coagulation assay for the detection of heterozygous and homozygous factor V Leiden--based resistance to activated protein C.
    Riewald M; Hintz G; Ritter M; Schmidt M; Neubauer A; Riess H
    Blood; 1996 Dec; 88(11):4398-9. PubMed ID: 8943880
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of storage conditions on activated protein C resistance assay.
    Trossaërt M; Conard J; Horellou MH; Samama MM
    Thromb Haemost; 1995 Jan; 73(1):163-4. PubMed ID: 7740489
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V.
    Talbot K; Song J; Hewitt J; Serrano K; Ho M; Carter CJ; MacGillivray RT; Pryzdial EL
    Br J Haematol; 2010 Oct; 151(2):198-200. PubMed ID: 20735394
    [No Abstract]   [Full Text] [Related]  

  • 12. The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant.
    Trossaërt M; Conard J; Horellou MH; Elalamy I; Samama MM
    Thromb Haemost; 1996 Mar; 75(3):521-2. PubMed ID: 8701421
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA; Fox EA; Longtine JA; Dorfman DM
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protein S functional assay yields unsatisfactory results in patients with activated protein C resistance.
    Simioni P; Gavasso S; Luni S; Invidiato S; Girolami A
    Blood Coagul Fibrinolysis; 1995 May; 6(3):286-7. PubMed ID: 7654942
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma resistance to activated protein C in venous and arterial thrombosis.
    Cushman M; Bhushan F; Bovill E; Tracy R
    Thromb Haemost; 1994 Oct; 72(4):647. PubMed ID: 7878648
    [No Abstract]   [Full Text] [Related]  

  • 19. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of lupus anticoagulant on a commercially available kit for APC-resistance.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Thromb Haemost; 1994 Oct; 72(4):645-6. PubMed ID: 7878647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.